Compounds > triphenyltetrazolium
Page last updated: 2024-08-21

triphenyltetrazolium and Nerve Degeneration

triphenyltetrazolium has been researched along with Nerve Degeneration in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liu, F; McCullough, LD; Schafer, DP1
Airavaara, M; Hoffer, B; Kuo, CC; Peränen, J; Saarma, M; Shen, H; Wang, Y1
Bähr, M; Hermann, DM; Holzmüller, H; Kilic, E; Kilic, U; Kügler, S; Schmeer, C1
Butler, TL; Collier, L; Collier, SN; De Mesquita, D; Duckworth, EA; Pennypacker, KR1
Cam, E; Hüdaoglu, O; Kilic, E; Schäbitz, WR; Yildiz, A; Yulug, B1

Other Studies

5 other study(ies) available for triphenyltetrazolium and Nerve Degeneration

ArticleYear
TTC, fluoro-Jade B and NeuN staining confirm evolving phases of infarction induced by middle cerebral artery occlusion.
    Journal of neuroscience methods, 2009, Apr-30, Volume: 179, Issue:1

    Topics: Analysis of Variance; Animals; Brain; Brain Chemistry; Brain Infarction; DNA-Binding Proteins; Fluoresceins; Infarction, Middle Cerebral Artery; Male; Mice; Mice, Inbred C57BL; Nerve Degeneration; Nerve Tissue Proteins; Neurons; Nuclear Proteins; Organic Chemicals; Severity of Illness Index; Staining and Labeling; Tetrazolium Salts; Time Factors

2009
Mesencephalic astrocyte-derived neurotrophic factor reduces ischemic brain injury and promotes behavioral recovery in rats.
    The Journal of comparative neurology, 2009, Jul-01, Volume: 515, Issue:1

    Topics: Animals; Apoptosis; Behavior, Animal; Brain; Brain Infarction; Cytoprotection; Disease Models, Animal; Humans; Hypoxia-Ischemia, Brain; Indicators and Reagents; Male; Motor Activity; Necrosis; Nerve Degeneration; Nerve Growth Factors; Nerve Tissue Proteins; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Recovery of Function; Staining and Labeling; Tetrazolium Salts; Treatment Outcome

2009
Adenovirus-mediated Bcl-X(L) expression using a neuron-specific synapsin-1 promoter protects against disseminated neuronal injury and brain infarction following focal cerebral ischemia in mice.
    Neurobiology of disease, 2002, Volume: 11, Issue:2

    Topics: Adenoviridae; Animals; bcl-X Protein; Brain Infarction; Brain Ischemia; Cell Death; Cerebrovascular Circulation; Gene Expression Regulation, Viral; Gene Transfer Techniques; Genetic Therapy; Genetic Vectors; Immunohistochemistry; Infarction, Middle Cerebral Artery; Male; Mice; Mice, Inbred C57BL; Nerve Degeneration; Promoter Regions, Genetic; Proto-Oncogene Proteins c-bcl-2; Synapsins; Tetrazolium Salts; Treatment Outcome

2002
Temporary focal ischemia in the mouse: technical aspects and patterns of Fluoro-Jade evident neurodegeneration.
    Brain research, 2005, Apr-25, Volume: 1042, Issue:1

    Topics: Animals; Biomarkers; Brain; Brain Injuries; Cell Death; Cerebral Cortex; Corpus Striatum; Disease Models, Animal; Fluoresceins; Fluorescent Dyes; Hippocampus; Infarction, Middle Cerebral Artery; Ischemic Attack, Transient; Mice; Mice, Inbred C57BL; Nerve Degeneration; Neurons; Organic Chemicals; Staining and Labeling; Tetrazolium Salts; Time Factors

2005
Olanzapine attenuates brain damage after focal cerebral ischemia in vivo.
    Brain research bulletin, 2006, Dec-11, Volume: 71, Issue:1-3

    Topics: Animals; Antipsychotic Agents; Benzodiazepines; Brain; Brain Ischemia; Cerebral Infarction; Cerebrovascular Circulation; Cytoprotection; Disease Models, Animal; Dose-Response Relationship, Drug; Infarction, Middle Cerebral Artery; Laser-Doppler Flowmetry; Male; Mice; Nerve Degeneration; Neuroprotective Agents; Olanzapine; Tetrazolium Salts; Treatment Outcome

2006